Clinical trial
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
NCT00057759
Study timeline
Study start (unknown)2003-01-01Date precision: month
Registry last updated2015-11-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Radiation Toxicityunresolved
Sexual Dysfunctionunresolved
Sexuality and Reproductive Issuesunresolved
Interventions
sildenafil citrateDRUG · verified · RxNorm: sildenafil citrate
PlaceboOTHER
Sponsors & collaborators
Radiation Therapy Oncology Grouplead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
MilwaukeeWisconsin, United States2TulsaOklahoma, United States2SpringfieldMissouri, United States2PhiladelphiaPennsylvania, United States1Ann ArborMichigan, United States1Salt Lake CityUtah, United States1BuffaloNew York, United States1Walnut CreekCalifornia, United States1LebanonNew Hampshire, United States1KalamazooMichigan, United States1AkronOhio, United States1RenoNevada, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00057759 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.